Andivio Labs · Free, no account
Every company gets a 0–100 score built from quality, financial health, growth, momentum, valuation and dividends — and the tool shows you which part of that number came from where. Free, no sign-up, nothing stored on our side.
What it does
Pick a strategy — dividends, undervalued, future leaders — and you get a shortlist of companies already analysed, each with a verdict and the reasoning that produced it. From there you can open any company and see the full picture.
The score runs 0–100 and is weighted across quality (margins, ROE), financial health (debt to equity), growth, momentum, valuation and dividend yield, with penalties for thin volume, extreme RSI or negative profitability. It ends in a plain verdict: buy confirmed, accumulate candidate or watch.
Sort every company in the S&P 500, mid-caps or the full list by score, market cap, P/E, yield or revenue growth — one sortable table, no page-by-page clicking.
Management changes, acquisitions, regulatory moves and earnings surprises, ranked by impact. Price-movement filler and listicles are stripped out before you see them.
Moving averages, MACD, RSI, Bollinger Bands and volume on a live chart, plus a markets dashboard covering indices, commodities and crypto with 52-week positioning.
Each indicator comes with an explanation of what it means and how to read it — P/E, ROE, free cash flow, debt ratios, chart patterns and the strategy setups behind the shortlists.
Honest about what it is
The tool explains its reasoning so you can disagree with it. Scores are computed from raw data that can contain errors, and nothing here is personalised financial advice — verify before you put real money anywhere.
The interface is in Romanian.
Andivio Labs
This is a side project, not what Andivio sells to businesses. If you are here for the company work, that is on the products page.
Newsletter
No schedule and no filler — a few times a year, on what actually worked. One click to leave.
